Your browser doesn't support javascript.
loading
Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors.
Shah, Hiral A; Fischer, James H; Venepalli, Neeta K; Danciu, Oana C; Christian, Sonia; Russell, Meredith J; Liu, Li C; Zacny, James P; Dudek, Arkadiusz Z.
Affiliation
  • Shah HA; Department of Medicine, Division of Hematology/Oncology.
  • Fischer JH; Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, IL.
  • Venepalli NK; Department of Pharmacy Practice, College of Pharmacy.
  • Danciu OC; Department of Medicine, Division of Hematology/Oncology.
  • Christian S; Department of Medicine, Division of Hematology/Oncology.
  • Russell MJ; Department of Medicine, Division of Hematology/Oncology.
  • Liu LC; Oncology Clinical Trials Office, University of Illinois Cancer Center.
  • Zacny JP; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago.
  • Dudek AZ; Department of Medicine, Division of Hematology/Oncology.
Am J Clin Oncol ; 42(5): 413-420, 2019 05.
Article in En | MEDLINE | ID: mdl-30973373

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Azepines / Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Oncol Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Azepines / Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Oncol Year: 2019 Type: Article